Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Transcenta Therapeutics Partners with WuXi Biologics for Strategic Collaboration on HiCB Bioprocessing Technologies.

Sep 09, 2026•about 3 hours ago

Contract Type

agreement

BiotechnologyHealth CareTherapeuticsBiopharma

Description

Transcenta Therapeutics has entered into a strategic collaboration agreement with WuXi Biologics, granting them a non-exclusive license to its HiCB platform. Transcenta will receive an upfront payment and milestone payments based on specified achievements, aimed at enhancing the development pipeline of complex biologic molecules.

Company Information

Company

Transcenta Therapeutics

About

Transcenta Therapeutics is a global clinical-stage biopharmaceutical company specializing in the discovery and development of antibody-based therapeutics. The company has fully integrated capabilities in research and development as well as in process development. Transcenta aims to significantly advance therapeutic solutions to meet health challenges. Their focus is on innovative bioprocessing technologies.

Predictive Intelligence
Strategic

ML-powered predictions for Transcenta Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Transcenta Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.